Spect and pet imaging of brain tumors

Neuroimaging Clinics of North America

Volumn 9, Issue 4, 1999, Pages 751-766

  Hustinx, R ^a   Alavi, A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHOLINE; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; IODINE 123; IODINE 131; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PENTETREOTIDE IN 111; RACLOPRIDE; RADIOPHARMACEUTICAL AGENT; SELEGILINE; SPIPERONE; SUCCIMER TC 99M; THALLIUM 201; TRITIUM; TYROSINE;

ASTROCYTOMA; BRAIN METABOLISM; BRAIN TUMOR; DIAGNOSTIC IMAGING; DRUG UPTAKE; GLIOBLASTOMA; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEURORADIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR DIAGNOSIS;

BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; RADIOACTIVE TRACERS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032701957     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (159)

1. Alavi JB, Alavi A, Chawluk J, et al: Positron emission tomography in patients with glioma: A predictor of prognosis. Cancer 62:1074-1078, 1988
2. Alexander ED, Loeffler JS, Schwartz RB, et al: Thallium-201 technetium-99m HMPAO single-photon emission computed tomography (SPECT) imaging for guiding stereotactic craniotomies in heavily irradiated malignant glioma patients. Acta Neurochir 122:215-217, 1993
3. Ancri D, Basset JY, Lonchampt MF, et al: Diagnosis of cerebral lesions by thallium 201. Radiology 128: 417-422, 1978
4. Andrews DW, Das R, Kim S, et al: Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistance. Neurosurgery 40:1323-1332, 1997
5. Bagni B, Pinna L, Tamarozzi R, et al: SPET imaging of intracranial tumours with 99Tcm-sestamibi. Nucl Med Commun 16:258-264, 1995
6. Baillet G, Albuquerque L, Chen Q, et al: Evaluation of single-photon emission tomography imaging of supratentorial brain gliomas with technetium-99m sestamibi. Eur J Nucl Med 21:1061-1066, 1994
7. Barker FG 2nd, Chang SM, Valk PE, et al: 18-FIuo-rodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 79: 115-126, 1997
8. Beauchesne P, Soler C, Maatougui K, et al: Is cerebral tomoscintigraphy with 99mTc-MIBI useful in the diagnosis of local recurrence in patients with malignant gliomas? Cancer Radiother 2:42-48, 1998
9. Bergstrom M, Muhr C, Jossan S, et al: Differentiation of pituitary adenoma and meningioma: Visualization with positron emission tomography and [HC]-L-de-prenyl. Neurosurgery 30:855-861, 1992
10. Bernât I, Toth G, Kovacs L: Tumour-like thallium-201 accumulation in brain infarcts, an unexpected finding on single-photon emission tomography [see comments]. Eur J Nucl Med 21:191-195, 1994
11. 123I]iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 30:110-112, 1989
12. Black KL, Hawkins RA, Kim KT, et al: Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 71:342-346, 1989
13. Brismar T, Collins VP, Kesselberg M: Thallium-201 uptake relates to membrane potential and potassium permeability in human glioma cells. Brain Res 500:30-36, 1989
14. Brown RS, Wahl RL: Overexpression of Glut-1 glucose transporter in human breast cancer: An immu-nohistochemical study. Cancer 72:2979-2985, 1993
15. Brunetti A, Fulham MJ, Aloj L, et al: Decreased brain glucose utilization in patients with Crafting's disease. J Nucl Med 39:786-790, 1998
16. Buchpiguel CA, Alavi JB, Alavi A, et al: PET versus SPECT in distaguishing radiation necrosis from tumor recurrence in the brain [clinical conference]. J Nucl Med 36:159-164, 1995
17. Carvalho PA, Schwartz RB, Alexander ED, et al: Detection of recurrent gliomas with quantitative thallium-201/technetium-99m HMPAO single-photon emission computerized tomography. J Neurosurg 77: 565-570, 1992
18. Chiù ML, Kronauge JF, Piwnica-Worms D: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisoni- trile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 31:1646-1653, 1990
19. D'Amico A, Messa C, Castagna A, et al: Diagnostic accuracy and predictive value of ""T1 SPECT for the differential diagnosis of cerebral lesions in AIDS patients. Nucl Med Commun 18:741-750, 1997
20. D'Aquino S, Cicciarello R, D'Avella D, et al: Effect of x-radiation to brain on cerebral glucose utilization in the rat. J Neurosurg Sci 34:215-218, 1990
21. 18F]2-fluoro-2- deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia [see comments]. AJNR Am J Neuroradiol 14:515-523, 1993
22. Delbeke D, Meyerowitz C, Lapidus RL, et al: Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47-52, 1995
23. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, et al: Uptake of the cation hexakis(2-methoxyisobutylisorurrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 50: 2198-2202, 1990
24. 11C]L-methi-onine uptake in gliomas. Neurosurgery 25:720-728, 1989
25. Derlon JM, Petit-Taboue MC, Chapon F, et al: The in vivo metabolic pattern of low-grade brain gliomas: A positron emission tomographic study using "F-fluorodeoxyglucose and "C-L-memylmethionine [see comments]. Neurosurgery 40:276-288, 1997
26. De Witte O, Hildebrand J, Luxen A, et al: Acute effect of carmustine on glucose metabolism in brain and glioblastoma. Cancer 74:2836-2842, 1994
27. de Wolde H, Pruim J, Mastik MF, et al: Proliferative activity in human brain tumors: Comparison of his-topathology and L-[1-(11)C]tyrosine PET. J Nucl Med 38.1369-1374, 1997
28. Di Chiro G: Positron emission tomography using ["F] fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22:360-371, 1987
29. 18F] fluorodeoxyglucose and positron emission tomography. Neurology 32:1323-1329, 1982
30. Di Chiro G, Hatazawa J, Katz DA, et al: Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: A PET study. Radiology 164:521-526, 1987
31. Di Chiro G, Oldfield E, Wright DC, et al: Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropatho-logic studies. AJR Am J Roentgenol 150:189-197, 1988
32. Dierckx RA, Martin JJ, Dobbeleir A, et al: Sensitivity and specificity of thallium-201 single-photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 21:621-633, 1994
33. 18F]FDG and 82Rb positron emission tomography. J Comput Assist Tomogr 11:563-570, 1987
34. Ericson K, Blomqvist G, Bergstrom M, et al: Application of a kinetic model on the methionine accumulation in intracranial tumours studied with positron emission tomography. Acta Radiol 28:505-509, 1987
35. 68Ga]EDTA in supratentorial tumors. J Comput Assist Tomogr 9:683-689, 1985
36. Fischman AJ, Thornton AF, Frosch MP, et al: FDG hypermetabolism associated with inflammatory necrotic changes following radiation of meningioma. J Nucl Med 38:1027-1029, 1997
37. Fulham MJ, Melisi JW, Nishimiya J, et al: Neuroim-aging of juvenile pilocytic astrocytomas: An enigma [see comments]. Radiology 189:221-225, 1993
38. Goethals P, Lameire N, van Eijkeren M, et al: [Methyl-carbon- 11] thymidine for in vivo measurement of cell proliferation. J Nucl Med 37:1048-1052, 1996
39. Goldman S, Levivier M, Pirotte B, et al: Regional methionine and glucose uptake in high-grade gliomas: A comparative study on PET-guided stereotactic biopsy [published erratum appears in J Nucl Med 1997 Dec;38(12):2002]. J Nucl Med 38:1459-1462, 1997
40. Gorniak RI, Kramer EL, McMeeking AA, et al: Thallium-201 uptake in cytomegalovirus encephalitis. J Nucl Med 38:1386-1388, 1997
41. Griffeth LK, Rich KM, Dehdashti F, et al: Brain metastases from non-central nervous system tumors: Evaluation with PET [see comments]. Radiology 186:37-44, 1993
42. Haldemarm AR, Rosier H, Barth A, et al: Somatostatin receptor scintigraphy in central nervous system rumors: Role of blood-brain barrier permeability. J Nucl Med 36:403-410, 1995
43. 11C]choline. J Nucl Med 38:842-847, 1997
44. Hatazawa J, Ishiwata K, Itoh M, et al: Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography. J Nucl Med 30:1809-1813, 1989
45. Herholz K, Pietrzyk U, Voges J, et al: Correlation of glucose consumption and tumor cell density in astrocytomas: A stereotactic PET study. J Neurosurg 79:853-858, 1993
46. Hirano T, Otake H, Kazama K, et al: Technetium-99m(V)-DMSA and thallium-201 in brain rumor imaging: Correlation with histology and malignant grade. J Nucl Med 38:1741-1749, 1997
47. Hoffman JM, Hanson MW, Friedman HS, et al: FDG-PET in pediatric posterior fossa brain tumors. J Comput Assist Tomogr 16:62-68, 1992
48. Holthoff VA, Herholz K, Berthold F, et al: In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment. Cancer 72:1394-1403, 1993
49. Holzer T, Herholz K, Jeske J, et al: FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr 17:681-687, 1993
50. 11C]carboxylic acid for detecting recurrent brain tumors. Clin Positron Imaging 1:165-173, 1998
51. Ishibashi M, Taguchi A, Sugita Y, et al: Thallium-201 in brain tumors: Relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 36:2201-2206, 1995
52. Ishikawa M, Kikuchi H, Miyatake S, et al: Glucose consumption in recurrent gliomas. Neurosurgery 33:28-33, 1993
53. Ishiwata K, Kubota K, Murakami M, et al: Re-evaluation of amino acid PET studies: Can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 34:1936-1943, 1993
54. Ishizu K, Nishizawa S, Yonekura Y, et al: Effects of hyperglycemia on FDG uptake in human brain and glioma [see comments]. J Nucl Med 35:1104-1109, 1994
55. Ito M, Patronas NJ, Di Chiro G, et al: Effect of moderate level x-radiation to brain on cerebral glucose utilization. J Comput Assist Tomogr 10:584-588, 1986
56. 18F] fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 33:540-548, 1993
57. Kallen K, Heiling M, Andersson AM, et al: Preoperative grading of glioma malignancy with thaUium-201 single-photon emission CT: Comparison with conventional CT. AJNR Am J Neuroradiol 17:925-932, 1996
58. Kallen K, Heiling M, Andersson AM, et al: Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT. J Neurol Neurosurg Psychiatry 63:569-574, 1997
59. Kao CH, Chang Lai SP, Chieng PU, et al: Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma: Relation to patient prognosis and chemotherapy response - a preliminary report. Cancer 83:64-68, 1998
60. Kaplan WD, Takvorian T, Morris JH, et al: Thallium-201 brain rumor imaging: A comparative study with pathologic correlation. J Nucl Med 28:47-52, 1987
61. Kaschten B, Stevenaert A, Sadzot B, et al: Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methio-nine. J Nucl Med 39:778-785, 1998
62. Kassis AI, Van den Abbeele AD, Wen PY, et al: Specific uptake of the auger electron-ernitting thymidine analogue 5-[123I/125I]iodo-2′- deoxyuridine in rat brain tumors: Diagnostic and therapeutic implications in humans. Cancer Res 50:5199-5203, 1990
63. Kawai K, Fujibayashi Y, Saji H, et al: A strategy for the study of cerebral amino add transport using io-dine-123-labeled amino acid radiopharmaceutical: 3-iodo-alpha-methyl-L-tyrosine. J Nucl Med 32:819-824, 1991
64. Kessler LS, Ruiz A, Donovan Post MI, et al: Thallium-201 brain SPECT of lymphoma in AIDS patients: Pitfalls and technique optimization. AJNR Am J Neuroradiol 19:1105-1109, 1998
65. Kim CK, Alavi JB, Alavi A, et al: New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neuro-oncol 10:85-91, 1991
66. Kim EE, Chung SK, Haynie TP, et al: Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. Radiographics 12:269-279, 1992
67. Kim KT, Black KL, Marciano D, et al: Thallium-201 SPECT imaging of brain tumors: Methods and results [see comments]. J Nucl Med 31:965-969, 1990
68. Kincaid PK, El-Saden SM, Park SH, et al: Cerebral gangliogliomas: Preoperative grading using FDG-PET and 201TI-SPECT [see comments]. AJNR Am J Neuroradiol 19:801-806, 1998
69. Klutmann S, Bohuslavizki KH, Brenner W, et al: Somatostatin receptor scintigraphy in postsurgical follow-up examinations of meningiomas. J Nucl Med 39:1913-1917, 1998
70. Kostakoglu L, Guc D, Canpinar H, et al: P-glycopro-tein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy. J Nucl Med 39:1191-1197, 1998
71. Kosuda S, Fujii H, Aoki S, et al: Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 30:1201-1206, 1994
72. Krishna L, Slizofski WJ, Katsetos CD, et al: Abnormal intracerebral thallium localization in a bacterial brain abscess. J Nucl Med 33:2017-2019, 1992
73. Kuwert T, Morgenroth C, Woesler B, et al: Uptake of iodine-123-alpha- methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 23:1345-1353, 1996
74. Kuwert T, Probst-Cousin S, Woesler B, et al: Iodine-123-alpha-methyl tyrosine in gliomas: Correlation with cellular density and proliferative activity. J Nucl Med 38:1551-1555, 1997
75. Langen KJ, Clauss RP, Holschbach M, et al: Comparison of iodotyrosines and methionine uptake in a rat glioma model. J Nucl Med 39:1596-1599, 1998
76. 124IMT and first clinical results. J Nucl Med 31:281-286, 1990
77. 123I]iodo-alpha-methyl tyrosine: Competition with natural L-amino acids [see comments]. J Nucl Med 32:1225-1229, 1991
78. 123I]iodo-alpha- methyltyrosine and [methyP'Cl-L-methionine uptake in cerebral gliomas: A comparative study using SPECT and PET. J Nucl Med 38:517-522, 1997
79. Lee JD, Kim DI, Lee JT, et al: Indium-111-pentetreo-tide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI. J Nucl Med 36:537-541, 1995
80. 18F] fluorodeoxyglucose. J Neurosurg 82:445-452, 1995
81. Lorberboym M, Mandell LR, Mosesson RE, et al: The role of thallium-201 uptake and retention in intracranial rumors after radiotherapy. J Nucl Med 38:223-226, 1997
82. Lorberboym M, Wallach F, Estok L, et al: Thallium-201 retention in focal intracranial lesions for differential diagnosis of primary lymphoma and nonma-lignant lesions in AIDS patients. J Nucl Med 39:1366-1369, 1998
83. 18F]fluoro-ethyl-spiperone. Eur J Nucl Med 24:1149-1155, 1997
84. Maffioli L, Gasparini M, Chiti A, et al: Clinical role of technetium-99m sestamibi single-photon emission tomography in evaluating pretreated patients with brain tumours. Eur J Nucl Med 23:308-311, 1996
85. Mankoff DA, Shields AF, Graham MM, et al: Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: Compartmental model and mathematical analysis. J Nucl Med 39:1043-1055, 1998
86. Maria BL, Drane WB, Quisling RJ, et al: Correlation between gadolinium-diethylenetriaminepentaacetic acid contrast enhancement and thallium-201 chloride uptake in pediatric brainstem glioma. J Child Neurol 12:341-348, 1997
87. Marriott CJ, Thorstad W, Akabani G, et al: Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-la-beled antibody for primary brain tumors. J Nucl Med 39:1376-1380, 1998
88. Matsumoto T, Tani E, Kaba K, et al: Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens. J Neurosurg 74:460-466, 1991
89. Mineura K, Sasajima T, Kowada M, et al: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73:2386-2394, 1994
90. Mogard J, Kihlstrom L, Ericson K, et al: Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: Diagnosis with PET-FDG. J Comput Assist Tomogr 18:177-181, 1994
91. Moretti JL, Duran Cordobes M, Starzec A, et al: Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J Nucl Med 39:1214-1218, 1998
92. Mousseau M, Chauvin C, Nissou MF, et al: A study of the expression of four chemoresistance-related genes in human primary and metastatic brain tumours. Eur J Cancer 29A:753-759, 1993
93. Muhr C, Bergstrom M: Positron emission tomography applied in the study of pituitary adenomas. J Endocrinol Invest 14:509-528, 1991
94. CDoherty MJ, Barrington SF, Campbell M, et al: PET scanning and the human immunodeficiency virus-positive patient. J Nucl Med 38:1575-1583, 1997
95. Ogawa T, Inugami A, Hatazawa J, et al: Clinical positron emission tomography for brain tumors: Comparison of fludeoxyglucose F 18 and L-methyl-"C-methionine. AJNR Am J Neuroradiol 17:345-353, 1996
96. Ogawa T, Kanno I, Hatazawa J, et al: Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 14:101-110, 1994
97. 18F-fluorodeoxyglucose and L-methyl-"C-methionine for diagnosis of recurrent brain tumor and radiation injury. Acta Radiol 32:197-202, 1991
98. Ogawa T, Miura S, Murakami M, et al: Quantitative evaluation of neutral amino acid transport in cerebral gliomas using positron emission tomography and fluorine-18 fluorophenylalanine. Eur J Nucl Med 23:889-895, 1996
99. Ogawa T, Shishido F, Kanno I, et al: Cerebral glioma: Evaluation with methionine PET [see comments]. Radiology 186:45-53, 1993
100. 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Com-mun 9:105-116, 1988
101. Olivero WC, Dulebohn SC, Lister JR: The use of PET in evaluating patients with primary brain rumours: Is it useful? J Neurol Neurosurg Psychiatry 58:250-252, 1995
102. Oriuchi N, Tamura M, Shibazaki T, et al: Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: Relationship to histologic grade, prognosis and proliferative activities [see comments]. J Nucl Med 34:2085-2089, 1993
103. Oriuchi N, Tomiyoshi K, Inoue T, et al: Independent thallium-201 accumulation and fluorine-18-fluoro-deoxyglucose metabolism in glioma. J Nucl Med 37:457-462, 1996
104. OTuama LA, Packard AB, Treves ST: SPECT imaging of pediatric brain tumor with hexakis (methoxyiso-butylisonitrile) technetium (I). J Nucl Med 31:2040-2041, 1990
105. O'Tuama LA, Treves ST, Larar JN, et al: Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain rumors: A within-subject comparison. J Nucl Med 34:1045-1051, 1993
106. 201T1 by a 9L gliosar-coma brain rumor model in rats. Nucl Med Biol 20:773-776, 1993
107. Patronas NJ, Brooks RA, DeLaPaz RL, et al: Glycolytic rate (PET) and contrast enhancement (CT) in human cerebral gliomas. AJNR Am J Neuroradiol 4:533-535, 1983
108. 18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology 144:885-889, 1982
109. Patronas NJ, Di Chiro G, Kufta C, et al: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62:816-822, 1985
110. Pirotte B, Goldman S, Bidaut LM, et al: Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy. Acta Neurochir (Wien) 134:79-82, 1995
111. Pirotte B, Goldman S, David P, et al: Stereotactic brain biopsy guided by positron emission tomography (PET) with [F-18] fluorodeoxyglucose and [C-11]me-thionine. Acta Neurochir Suppl 68:133-138, 1997
112. Piwnica-Worms D, Kronauge JF, Chiu ML: Uptake and retention of hexakis (2-methoxyisobutyl isoni-trile) technerium (I) in cultured chick myocardial cells: Mitochondrial and plasma membrane potential dependence. Circulation 82:1826-1838, 1990
113. Piwnica-Worms D, Rao W, Kronauge JF, et al: Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation. Biochemistry 34:12210-12220, 1995
114. Powe JE, Alavi J, Alavi A, et al: Cerebral metabolic changes in patients with brain tumors demonstrated by positron emission tomography. J Neuroimag 2:1-7, 1992
115. Pruim J, Willemsen AT, Molenaar WM, et al: Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate. Radiology 197:221-226, 1995
116. Rao W, Chiu ML, Kronauge JF, et al: Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 35:510-515, 1994
117. 11C]deoxyglucose. J Cereb Blood How Metab 5:179-192, 1985
118. Reubi JC, Horisberger U, Lang W, et al: Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors. Am J Pathol 134:337-344, 1989 .
119. Reubi JC, Maurer R, Klijn JG, et al: High incidence of somatostatin receptors in human meningiomas: Biochemical characterization. J Clin Endocrinol Metab 63:433-438, 1986
120. Ricci PE, Karis JP, Heiserman JE, et al: Differentiating recurrent tumor from radiation necrosis: Time for re-evaluation of positron emission tomography? [see comments]. AJNR Am J Neuroradiol 19:407-413, 1998
121. Roelcke U: PET: Brain tumor biochemistry. J Neu-rooncol 22:275-279, 1994
122. Roelcke U, Blasberg RG, von Ammon K, et al: Dexa-methasone treatment and plasma glucose levels: Relevance for fluorine-18-fluorodeoxy glucose uptake measurements in gliomas. J Nucl Med 39:879-884, 1998
123. Roelcke U, Radu E, Ametamey S, et al: Association of rubidium and C-methionine uptake in brain tumors measured by positron emission tomography. J Neurooncol 27:163-171, 1996
124. 11C]methionine and rubidium-82 using PET. J Neurol Sci 132:20-27, 1995
125. Rollins NK, Lowry PA, Shapiro KN: Comparison of gadolinium-enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg 22:8-14, 1995
126. Rosenfeld SS, Hoffman JM, Coleman RE, et al: Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography. J Nucl Med 33:532-536, 1992
127. Rozental JM, Cohen JD, Mehta MP, et al: Acute changes in glucose uptake after treatment: The effects of carmustine (BCNU) on human glioblastoma multiforme. J Neurooncol 15:57-66, 1993
128. Rozental JM, Levine RL, Mehta MP, et al: Early changes in tumor metabolism after treatment: The effects of stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 20:1053-1060, 1991
129. Rozental JM, Levine RL, Nickles RJ: Changes in glucose uptake by malignant gliomas: Preliminary study of prognostic significance. J Neurooncol 10:75-83, 1991
130. Sasaki M, Ichiya Y, Kuwabara Y, et al: Ring-like uptake of FDG in brain abscess: A PET study. J Comp Assist Tomogr 14:486-487, 1990
131. Sasaki M, Kuwabara Y, Yoshida T, et al: A comparative study of thalhum-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumors. Eur J Nucl Med 25:1261-1269, 1998
132. Schifter T, Hoffman JM, Hanson MW, et al: Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors. J Comput Assist Tomogr 17:509-561, 1993
133. Schillaci O, Danieli R, Tavolaro R, et al: Tc-99m tetro-fosmin accumulation in lung cancer and its metastases. Clin Nucl Med 22:46-47, 1997
134. Schmidt M, Scheidhauer K, Luyken C, et al: Somatostatin receptor imaging in intracranial tumours. Eur J Nucl Med 25:675-686, 1998
135. Schwartz RB, Carvalho PA, Alexander ED, et al: Radiation necrosis vs high-grade recurrent glioma: Differentiation by using dual-isotope SPECT with 201T1 and 99mTc-HMPAO. AJNR Am J Neuroradiol 12:1187-1192, 1991
136. Schwartz RB, Holman BL, Polak JF, et al: Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: Association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 89:60-68, 1998
137. Shih WJ, Kadzielawa K, Lee C, et al: Tc-99m sestamibi uptake by cerebellar metastasis from bronchogenic carcinoma [see comments]. Clin Nucl Med 18:887-890, 1993
138. Soricelli A, Cuocolo A, Varrone A, et al: Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: Comparison with thallium-201 imaging. J Nucl Med 39:802-806, 1998
139. Taki J, Sumiya H, Asada N, et al: Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy. J Nucl Med 39:1179-1184, 1998
140. 18F-fluorodeoxyglucose and single photon emission computed tomography with thallium-201 chloride. Neuroradiology 40:210-215, 1998
141. Tedeschi E, Soricelli A, Brunetti A, et al: Different thallium-201 single-photon emission tomographic patterns in benign and aggressive meningiomas. Eur J Nucl Med 23:1478-1484, 1996
142. Tjuvajev JG, Macapinlac HA, Daghighian F, et al: Imaging of brain tumor proliferative activity with io-dine-131-iododeoxyuridine. J Nucl Med 35:1407-1417, 1994
143. Tonami N, Matsuda H, Ooba H, et al: ThaUium-201 accumulation in cerebral candidiasis: Unexpected finding on SPECT. Clin Nucl Med 15:397-400, 1990
144. Tyler JL, Diksic M, Villemure JG, et al: Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 28:1123-1133, 1987
145. Ueda T, Kaji Y, Wakisaka S, et al: Time sequential single photon emission computed tomography studies in brain tumour using thallium-201. Eur J Nucl Med 20:138-145, 1993
146. Valk P, Budinger T, Levin V, et al: PET of malignant cerebral activity and correlation with clinical outcome. J Neurosurg 69:830-838, 1988
147. Valk PE, Budinger TF, Levin VA, et al: PET of malignant cerebral tumors after interstitial brachytherapy: Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 69:830-838, 1988
148. Vander Borght T, Lambotte L, Pauwels S, et al: Noninvasive measurement of liver regeneration with positron emission tomography and [2-11C]thymidine. Gastroenterology 101:794-799, 1991
149. Vertosick FT Jr, Selker RG, Grossman SJ, et al: Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 34:396-401, 1994
150. Vulringer K, Jager H, Dichgans M, et al: Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr 19:532-536, 1995
151. Wang GJ, Volkow ND, Lau YH, et al: Glucose metabolic changes in nontumoral brain tissue of patients with brain tumor following radiotherapy. A preliminary study. J Comput Assist Tomogr 20:709-714, 1996
152. Warburg O: The Metabolism of Tumors. London, Arnold Constable, 1930
153. Weber W, Bartenstein P, Gross MW, et al: Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors. J Nucl Med 38:802-808, 1997
154. Wienhard K, Herholz K, Coenen HH, et al: Increased amino acid transport into brain tumors measured by PET of L-(2-18F)fluorotyrosine [see comments]. J Nucl Med 32:1338-1346, 1991
155. Willemsen AT, van Waarde A, Paans AM, et al: In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET. J Nucl Med 36:411-419, 1995
156. 18F-deoxyglucose. Eur J Nucl Med 24:428-434, 1997
157. 99Tc-sestamibi SPET? Eur J Nucl Med 25:401-409, 1998
158. Yoshii Y, Satou M, Yamamoto T, et al: The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 20:39-45, 1993
159. Zingale A, Musumeci S, Nicoletti G, et al: Thallium-201-SPECT and 99Tc-HM-PAO SPECT imaging to study functionally cerebral supratentorial neoplasms: The biological basis of the functional imaging interpretation. J Neurosurg Sri 39:227-235, 1995.